Zobrazeno 1 - 10
of 21
pro vyhledávání: '"N Yu Kashirskaya"'
Autor:
S A Krasovsky, E L Amelina, A V Chernyak, V S Nikonova, A Yu Voronkova, N Yu Kashirskaya, N I Kapranov, V P Chistyakova, V A Samoilenko, S Yu Semykin, O I Simonova, N V Petrova, Yu V Gorinova, A G Chuchalin
Publikováno v:
Терапевтический архив, Vol 84, Iss 3, Pp 54-58 (2012)
Aim. To estimate survival median and its changes, number of patients over 18 years of age for 1991—2000 and 2001-2010 for 20-year period (1991-2010), to elucidate factors affecting survival for 2001—2010 in mucoviscidosis children living in Mosco
Externí odkaz:
https://doaj.org/article/b6d3026bd05d474ab3ca03632235560b
Autor:
E. I. Kondratyeva, A. I. Tlif, A. Yu. Voronkova, E. L. Amelina, N. Yu. Kashirskaya, S. A. Krasovsky, M. A. Starinova, T. L. Kuraeva
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 418-426 (2023)
BACKGROUND: In recent decades, the life expectancy of patients with CF has increased, which leads to an increase in the frequency of conditions associated with impaired carbohydrate metabolism.AIM: to analyze the impact of cystic fibrosis-associated
Externí odkaz:
https://doaj.org/article/12a6b36fd78d452fba1270a44826dc92
Autor:
E. I. Kondratyeva, A. Yu. Voronkova, N. Yu. Kashirskaya, S. A. Krasovsky, M. A. Starinova, E. L. Amelina, S. N. Avdeev, S. I. Kutsev
Publikováno v:
PULMONOLOGIYA. 33:171-181
A registry of patients with cystic fibrosis (CF) of the Russian Federation has been compiled annually since 2011. Analysis of the national registry with large amounts of clinical and laboratory data helps understand changes in demographic indicators,
Autor:
N. Yu. Kashirskaya, N. V. Petrova, T. E. Gembitskaya, T. E. Ivashchenko, A. I. Khavkin, O. N. Nesteruk, E. K. Ginter, S. I. Kutsev, R. A. Zinchenko
Publikováno v:
Experimental and Clinical Gastroenterology. :150-159
Preconceptional genetic screening (genetic testing of individuals at the stages of family planning and birth of a healthy child) has an important place in the prevention of hereditary diseases. This review focuses on the preconceptional prevention of
Autor:
N. Yu. Kashirskaya, N. V. Petrova, T. E. Gembitskaya, T. E. Ivashchenko, A. I. Khavkin, O. N. Nesteruk, E. K. Ginter, S. I. Kutsev, R. A. Zinchenko
Publikováno v:
Experimental and Clinical Gastroenterology. :160-170
This text is a continuation of a review of international studies and guidelines/recommendations for primary prevention of cystic fibrosis (CF). This section reviews the selection of pathogenic variants for different CF mutation carrier screening prog
Autor:
N. V. Lyabina, O. I. Simonova, I. V. Shirokova, V. P. Chernevich, A. S. Batyrova, А. A. Marushina, A. I. Khavkin, A. Е. Krasnovidova, N. Yu. Kashirskaya
Publikováno v:
Experimental and Clinical Gastroenterology. :93-106
Th e article presents a review on a cystic fibrosis-r elated diabetes, a severe complication of cystic fi brosis in children, which has acquired increasing importance and revealed to contribute in prognosis of the disease in recent years. Which inc
Autor:
N. Yu. Kashirskaya, S. A. Krasovsky, A. V. Chernyak, V. D. Sherman, A. Yu. Voronkova, L. A. Shabalova, V. S. Nikonova, Yu. V. Gorinova, O. I. Simonova, E. L. Amelina, E. I. Kondrat’eva, N. I. Kapranov, N. V. Petrova, R. A. Zinchenko
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 503-508 (2015)
Cystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We performed a retrospective analysis of the trends in life expectancy of cystic fibrosis patie
Externí odkaz:
https://doaj.org/article/469ac005c5ab44a3b76219cbd0d47e2f
Autor:
Ye. L. Amelina, I. K. Asherova, I. K. Volkov, Т. Ye. Gembitskaya, Ye. K. Ginter, N. А. Il’yenkova, N. I. Kapranov, I. P. Karimova, N. Yu. Kashirskaya, Ye. I. Kondrat’yeva, М. N. Kostyleva, S. А. Krasovsky, N. B. Merzlova, L. P. Nazarenko, L. S. Namazova-Baranova, А. F. Neretina, V. S. Nikonova, А. V. Orlov, S. S. Postnikov, Т. А. Protasova, S. Yu. Semykin, D. F. Sergienko, О. I. Simonova, I. D. Uspenskaya, М. Yu. Chernukha, L. А. Shabalova, I. А. Shaginyan, V. D. Sherman
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 6, Pp 89-95 (2014)
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including gluco
Externí odkaz:
https://doaj.org/article/6524667aa0ed4fb08cf3767cd4dcf923
Autor:
S. A. Krasovskii, N. Yu. Kashirskaya, M. V. Usacheva, E. L. Amelina, A. V. Chernyak, Zh.K. Naumenko
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 2, Pp 36-43 (2014)
Background: To establish features of a clinical course of a disease at patients depending on age of firstly determine diagnosis of cystic fibrosis. Patients and methods: We examined 130 patients with cystic fibrosis aged under 25 years old. Depending
Externí odkaz:
https://doaj.org/article/b34b275b0d2c4dc6aed3a9e34d11d79f
Autor:
E. I. Kondratyeva, S. A. Krasovsky, N. Yu. Kashirskaya, E. L. Amelina, E. K. Zhekaite, V. D. Sherman, O. I. Simonova, Yu. V. Gorinova, E. V. Boitsova, M. A. Mukhina, I. N. Butyugina, M. A. Makarova, A. B. Malakhov
Publikováno v:
PULMONOLOGIYA. 30:544-552
Since the beginning of the COVID-19 epidemic, the European cystic fibrosis society (ECFS) has decided to launch a special ECFS-COVID-19 program to collect information on the of COVID-19 characteristics in the patients with cystic fibrosis (CF). The r